About this Report

This report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and sales forecasts by country and market segment, including:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country.  Also, the report:

     -  Examines market applications of Molecular Diagnostics,  
        Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

     -  Reviews features and operating characteristics of major analyzers used
        for STD testing;

     -  Profiles key suppliers and potential market entrants developing innovative
        technologies and products; and

     -  Analyzes emerging opportunities, alternative market penetration strategies,
         market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.

Contains 350 pages and 90 tables

 

Table Of Contents

Table of Contents and List of Tables

I. Introduction
II. Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Papillomavirus (HPV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and DrugsTable of Contents (continued)
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. France: Market Size, Growth and Major Suppliers’
Sales and Market Shares
IV. Germany: Market Size, Growth and Major Suppliers’
Sales and Market Shares
V. Italy: Market Size, Growth and Major Suppliers’
Sales and Market Shares
VI. Japan: Market Size, Growth and Major Suppliers’
Sales and Market Shares
VII. Spain: Market Size, Growth and Major Suppliers’
Sales and Market Shares
VIII. UK: Market Size, Growth and Major Suppliers’
Sales and Market Shares
IX. USA: Market Size, Growth and Major Suppliers’
Sales and Market SharesTable of Contents (continued)
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- FujirebioTable of Contents (continued)
- Gen-Probe
- Hologic
- ID Biomedical
- Innogenetics/Solvay
- Kreatech
- Life Technology
- Lonza
- Nanogen/Elitech
- Novartis Diagnostics
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac
- WakoSexually-Transmitted Diseases
Global Market Outlook and Opportunities
List of Tables
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Pap Smear/HPV Tests
Major Companies Developing or Marketing Syphilis Tests
France
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Chlamydia Diagnostics Sales by Major Supplier
France
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
France
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Herpes Testing Market Diagnostics Sales
by Major SupplierList of Tables (continued)
France
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Papillomavirus (HPV) Test Volume and Diagnostics Sales
Forecast by Market Segment
France
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Syphilis Testing Market Diagnostics Sales
by Major Supplier
Germany
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Germany
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market SegmentList of Tables (continued)
Germany
Herpes Testing Market Diagnostics Sales
by Major Supplier
Germany
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Italy
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market SegmentList of Tables (continued)
Italy
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Chlamydia Diagnostics Sales by Major Supplier
Japan
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Japan
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan
Herpes Testing Market Diagnostics Sales
by Major SupplierList of Tables (continued)
Japan
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Syphilis Testing Market Diagnostics Sales
by Major Supplier
Spain
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Chlamydia Diagnostics Sales by Major Supplier
Spain
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market SegmentList of Tables (continued)
Spain
Herpes Testing Market Diagnostics Sales
by Major Supplier
Spain
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Syphilis Testing Market Diagnostics Sales
by Major Supplier
U.K.
Chancroid
Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.K.
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market SegmentList of Tables (continued)
U.K.
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K.
Herpes Testing Market Diagnostics Sales
by Major Supplier
U.K.
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K.
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Syphilis Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Chancroid Diagnostics Sales by Major Supplier
U.S.A.
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Chlamydia Diagnostics Sales by Major SupplierList of Tables (continued)
U.S.A.
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Herpes Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Syphilis Testing Market Diagnostics Sales
by Major Supplier

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 21 100
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. “2014 Strategies for the Global Microbiology Testing Market” is a new seven-country strategic analysis ...

Analysis of the Global In Vitro Diagnostics Market

Analysis of the Global In Vitro Diagnostics Market

  • $ 10 000
  • Industry report
  • July 2014
  • by Frost & Sullivan

Slowing US and European Markets Demand Alignment with Global Market Needs Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.